Health Trials

Intracranial Hemorrhage

2

Review clinical trials related to Intracranial Hemorrhage. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clearance of Intracranial Blood Products by Continuous Irrigation With the IRRAflow System

The study is a multi-center prospective cohort, controlled, phase 4 post-market registry evaluating the efficacy and radiographic outcomes associated with the use of the IRRAflow® Active Fluid Exchange System compared to standard of care external ventricular drains.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Christopher P KellnerUpdated: Oct 28, 2025Locations: 1Duration: 6 Months
Eligibility criteria

Age >=18 years of age [+4]

GCS ≤ 5 [+3]

Read more
Status: Recruiting

Statins for Treatment of Primary Intracerebral Hemorrhage

The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.

Participants needed: 264
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: The Second Hospital of Anhui Medical UniversityUpdated: Jul 28, 2025Locations: 22
Eligibility criteria

Patients with a diagnosis of spontaneous intracerebral hemorrhage (ICH) confirme... [+7]

ICH secondary to trauma, tumor, aneurysm, arteriovenous malformation (AVM), vasc... [+6]

Read more